According to Coya Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.35. At the end of 2024 the company had a P/S ratio of 10.8.
Year | P/S ratio | Change |
---|---|---|
2024 | 10.8 | -39.42% |
2023 | 17.8 | |
2022 | N/A |